October 2, 2014
LAS VEGAS — In a new study, patients who experienced HF-related hospitalization or required unscheduled outpatient HF treatment exhibited worsening rapid shallow breathing in the 7 days before the event.
At the Heart Failure Society of America Annual Scientific Meeting, researchers presented data on 52 adults enrolled in the MultiSENSE trial, a nonrandomized feasibility study designed to evaluate the ability of multiple sensors in an implantable cardioverter defibrillator to detect early signs of worsening HF. The mean age of the patients was 66.4 years and 72.7% were men. All patients had been implanted with Cognis cardiac resynchronization therapy defibrillators (CRT-Ds; Boston Scientific).